Advancements in Cord Blood Expansion Technologies

Advancements in Cord Blood Expansion Technologies

Gamida Cell received FDA approval for its allogeneic cell therapy, Omisirge: a new expanded cord blood cell source for stem cell transplantation.Omisirge may increase access to stem cell transplants, including among patients from diverse backgrounds.


Read More


Additional Treatment Benefits For Patients: Our Exclusive License Agreement

Additional Treatment Benefits For Patients: Our Exclusive License Agreement

The work of Dr. Joanne Kurtzberg and her colleagues at Duke University aims to bring novel cord blood and cord tissue-based cellular therapies to the clinic. Per the license agreement, additional patients will be provided access to cord blood and cord tissue treatments under Investigational New Drug Applications (INDs) currently held by Duke at a forthcoming Cryo-Cell stem cell infusion clinic, expected to open in early 2022.


Read More


UC-MSCs Are Explored For Treatment of Spine Conditions

UC-MSCs Are Explored For Treatment of Spine Conditions

Bone marrow MSCs, adipose tissue MSCs, umbilical cord MSCs and mononuclear cells have long been used in transplantations for a wide array of treatments. Umbilical cord blood and cord tissue-derived mesenchymal stem cells (UC-MSCs) are undergoing several clinical trial phases to test the safety and efficacy for use in infusions for patients with low back pain (LBP), intervertebral disc degeneration (IVD), and spinal cord injury (SCI).


Read More


Innovative Cord Blood Monocyte Cell Therapies

Innovative Cord Blood Monocyte Cell Therapies

Dr. Joanne Kurtzberg was present at the annual Cryo-Cell International conference to deliver news of her latest work on cell expansion technologies and to share success stories of former cord blood transplant patients. 


Read More


Banking Each Child's Cord Blood is Critical for Sibling Use

Banking Each Child's Cord Blood is Critical for Sibling Use

Sibling-directed donation has been implemented in numerous successful cord blood transplantations, and families should be advised of the many benefits associated with preserving each of their children’s umbilical stem cells. In this article, we will highlight five specific benefits.


Read More


An Update on Clinical Trials Using Cord Blood and Cord Tissue

An Update on Clinical Trials Using Cord Blood and Cord Tissue

Stem cells obtained from cord blood and cord tissue are being utilized in regenerative medicine for a varying host of conditions. The most recent research indicates promising results for the treatment of neurological disorders, immune deficiencies, perinatal brain injuries, as well as degenerative diseases, and skin abnormalities.


Read More


Age Major Factor in Stem Cell Transplantation Success

Age Major Factor in Stem Cell Transplantation Success

In HLA-matched transplants, younger donor age was the only factor reliably associated with patient survival. Other secondary selection characteristics included sex, ethnicity, the presence of cytomegalovirus and non-HLA and HLA genetic factors. Several factors are believed to inhibit the proper functioning of stem cells as the donor ages, making the young stem cells in cord blood a beneficial source when HLA-matching is equal.


Read More


Enhancing Cord Blood Banking through Advancements in Expansion Technologies

Enhancing Cord Blood Banking through Advancements in Expansion Technologies

Ex vivo expansion has the potential to greatly increase the use of cord blood stem cells as a standard treatment. A growing number of studies are looking at various methods of expanding cord blood stem cells, and a number of these studies are in the second and third phases, suggesting that ex vivo expansion protocols are proving safe, effective and feasible.


Read More


The Zika Virus Risk & Cord Blood Banking

The Zika Virus Risk & Cord Blood Banking

For everyone other than pregnant moms, the Zika virus poses only a small risk. It’s a much more serious situation for expecting moms, regardless of which trimester they are in. Zika can be passed from a pregnant woman to her fetus. When it comes to preserving cord blood during the time that people are worried  about Zika spreading, Cryo-Cell International has taken  extensive precautions to ensure safe storage of all units.

Read More


Cord Blood for Brain Injury: A Synopsis of the Latest Research

Cord Blood for Brain Injury: A Synopsis of the Latest Research

As it stands now, available treatments for neurological injuries are limited in scope. Most therapies are aimed at managing the symptoms of the conditions rather than the underlying causes. There is tremendous interest—and strides being made—in developing stem cell therapies as potential treatments. The use of umbilical cord blood as a source of stem cells for such therapies represents a potential sea change in treatments and results.
 

Read More


Cryo-Cell International

Cryo-Cell HQ
 
The World’s First Cord Blood Bank

Founded in 1989, Cryo-Cell is the world's first family cord blood bank.  More than 500,000 parents from 87 countries have entrusted Cryo-Cell (and our affiliates) with their baby’s cord blood collections.  Since inception, 100% of our clients’ collections have been successfully viable upon thaw, a statement that no other cord blood bank has made. Cryo-Cell's services include umbilical cord blood and cord tissue banking. Cryo-Cell's industry leading, state-of-the-art laboratory and storage facility are situated adjacent to its corporate headquarters. This proximity allows our executives to directly oversee the daily operation of the most secured, efficient, and technically advanced facility.